Annual Long Term Debt
$3.77 M
-$468.00 K-11.05%
31 December 2023
Summary:
Acrivon Therapeutics Common Stock annual long term debt is currently $3.77 million, with the most recent change of -$468.00 thousand (-11.05%) on 31 December 2023. During the last 3 years, it has risen by +$3.77 million (+100.00%). ACRV annual long term debt is now -24.11% below its all-time high of $4.96 million, reached on 31 December 2021.ACRV Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$2.97 M
-$270.00 K-8.33%
30 September 2024
Summary:
Acrivon Therapeutics Common Stock quarterly long term debt is currently $2.97 million, with the most recent change of -$270.00 thousand (-8.33%) on 30 September 2024. Over the past year, it has dropped by -$671.00 thousand (-18.41%). ACRV quarterly long term debt is now -40.11% below its all-time high of $4.96 million, reached on 01 December 2021.ACRV Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.1% | -18.4% |
| 3 y3 years | +100.0% | -40.1% |
| 5 y5 years | - | - |
ACRV Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -24.1% | -40.1% | at low | |
| 5 y | 5 years | -24.1% | -40.1% | at low | |
| alltime | all time | -24.1% | -40.1% | at low |
Acrivon Therapeutics Common Stock Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.97 M(-8.3%) |
| June 2024 | - | $3.24 M(-7.4%) |
| Mar 2024 | - | $3.50 M(-7.1%) |
| Dec 2023 | $3.77 M | $3.77 M(+3.4%) |
| Sept 2023 | - | $3.64 M(-5.3%) |
| June 2023 | - | $3.85 M(-4.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.05 M(-4.5%) |
| Dec 2022 | $4.24 M(-14.7%) | $4.24 M(-4.2%) |
| Sept 2022 | - | $4.42 M(-4.0%) |
| June 2022 | - | $4.60 M(-7.3%) |
| Dec 2021 | $4.96 M(>+9900.0%) | - |
| Dec 2021 | - | $4.96 M |
| Dec 2020 | $0.00 | - |
FAQ
- What is Acrivon Therapeutics Common Stock annual long term debt?
- What is the all time high annual long term debt for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock annual long term debt year-on-year change?
- What is Acrivon Therapeutics Common Stock quarterly long term debt?
- What is the all time high quarterly long term debt for Acrivon Therapeutics Common Stock?
- What is Acrivon Therapeutics Common Stock quarterly long term debt year-on-year change?
What is Acrivon Therapeutics Common Stock annual long term debt?
The current annual long term debt of ACRV is $3.77 M
What is the all time high annual long term debt for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high annual long term debt is $4.96 M
What is Acrivon Therapeutics Common Stock annual long term debt year-on-year change?
Over the past year, ACRV annual long term debt has changed by -$468.00 K (-11.05%)
What is Acrivon Therapeutics Common Stock quarterly long term debt?
The current quarterly long term debt of ACRV is $2.97 M
What is the all time high quarterly long term debt for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high quarterly long term debt is $4.96 M
What is Acrivon Therapeutics Common Stock quarterly long term debt year-on-year change?
Over the past year, ACRV quarterly long term debt has changed by -$671.00 K (-18.41%)